Section Arrow
Quote
AMRX.NASDAQ
- Amneal Pharmaceuticals
Quotes are at least 15-min delayed:2026/06/30 17:34 EDT
After Hours
Last
 17.31
0 (0.00%)
Bid
17.2
Ask
17.95
High 17.62 
Low 17.2 
Volume 108.06K 
Regular Hours (Closed)
Last
 17.31
+0.02 (+0.12%)
Day High 
17.49 
Prev. Close
17.29 
1-M High
17.86 
Volume 
2.24M 
Bid
17.2
Ask
17.95
Day Low
17.17 
Open
17.3 
1-M Low
12.49 
Market Cap 
5.52B 
Currency 美元 
P/E 46.73 
%Yield -- 
10-SMA 16.69 
20-SMA 15.44 
50-SMA 13.85 
52-W High 17.86 
52-W Low 7.665 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.37/0.96
Enterprise Value
8.18B
Balance Sheet
Book Value Per Share
-0.14
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
3.02B
Operating Revenue Per Share
7.25
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health34.67+1.28+3.83%-- 
After Hours 34.39 -0.28 -0.81%
VTRSViatris15.88-0.35-2.16%-- 
After Hours 15.88 0 0.00%
ZTSZOETIS71.86-1.39-1.90%12.01PE
After Hours 72 +0.14 +0.19%
BCRXBioCryst Pharmaceuticals10+0.45+4.71%-- 
After Hours 9.97 -0.03 -0.30%
HLNHaleon plc9.33----19.02PE
After Hours 9.26 -0.07 -0.75%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.